HMH Maestro
  • Action Center
  • Topics
  • On-Call Schedules
  • CME
  • Helpful Tools
Open main menu
  • Action Center
  • Topics
  • On-Call Schedules
  • CME
  • Helpful Tools
  • Topics
  • Hospitals and Locations
  • HMH and Carenostics Receive Innovative Practice Award for AIDriven Tool Used to Diagnose Kidney Disease

HMH and Carenostics Receive Innovative Practice Award for AIDriven Tool Used to Diagnose Kidney Disease

Published:
September 20, 2023

What You Need To Know

Hackensack Meridian Health, along with Carenostics, a leading healthcare artificial intelligence (AI) company, recently accepted Bio-IT World’s Innovative Practice Award for their joint project that leverages AI for earlier clinical intervention in chronic kidney disease. The Innovative Practice Award highlights outstanding examples of how technology innovations and strategic partnerships can be applied to advance healthcare and life sciences research. The Carenostics and HMH teams were specifically honored for their work in clinical diagnostics.

Carenostics is an HMH partner working with the health network to develop machine-learning models that can predict previously undiagnosed and underdiagnosed kidney disease cases. This technology integrates various data sources, including electronic health records to generate recommendations for clinicians to consider for their patients' care.

This collaboration has led to the development of a capability called CKDx, which analyzes billions of data points to recognize novel correlations and provide clear, insightful recommendations to clinicians. In addition to supplying diagnostic recommendations, CKDx will predict hospitalizations and future cardio-renal complications using biomarkers recorded in patient records. Retrospective experiments have demonstrated that this technology has the ability to identify more than 50% of undiagnosed Stage 3 (or later) kidney disease patients.

The Carenostics team has been working closely with clinical and technical team members from HMH to launch and maintain this partnership; Dr. Thomas Salazer, Chief of Nephrology at Hackensack University Medical Center and Dr. Suelyn Boucree are the clinical champions for the initiative.

The partnership between HMHand Carenostics has been in place for less than a year, and the teams are already working towards expanding to additional therapeutic areas such as asthma, chronic obstructive pulmonary disease (COPD), and heart failure. This collaboration was one of just six projects recognized for this year's Bio-IT World award. Kash Patel, Kanishka Rao, and Carenostics Co-Founder and CEO Bharat Rao accepted the award on behalf of HMH and Carenostics at the Bio-IT World Conference and Expo in Boston on May 16, 2023.

    1. Clinical Alerts
    2. Featured Physicians
    3. Featured Specialties
    4. HMH Partners Updates
    5. Hospitals and Locations
    6. IT Alerts
    7. Leadership Announcements
    8. Legal and Regulatory
    9. Payor Updates
    10. Physician Tips
    11. Quality and Safety
    • Topics
    • Hospitals and Locations
    • HMH and Carenostics Receive Innovative Practice Award for AIDriven Tool Used to Diagnose Kidney Disease

    About HMH Maestro

    • Accessibility Statement
    • Careers

    Information

    • Visitors/Guests
    • Patients

    Privacy Policy|Terms & Conditions
    © 2026
    Hackensack Meridian Health, Inc.